Epilepsy, Rolandic

Also known as: Rolandic Epilepsy, Benign / Benign Childhood Epilepsy With Centrotemporal Spikes / Benign rolandic epilepsy / Benign Childhood Epilepsy With Centro-Temporal Spikes / Benign Childhood Epilepsy With Centro-temporal Spikes (BCECTS) / Rolandic Epilepsy / Benign Rolandic epilepsy (disorder)

DrugDrug NameDrug Description
DB08329SulthiameA carbonic anhydrase inhibitor used primarily in benign focal epilepsies of childhood that may be useful as an adjunct therapy in a variety of other refractory epilepsies.
DrugDrug NameTargetType
DB08329SulthiameCarbonic anhydrase 2target
DrugDrug NamePhaseStatusCount
DB01202Levetiracetam1Completed1
DB01202Levetiracetam3Terminated1
DB08329Sulthiame3Terminated1
DB00564Carbamazepine4Terminated1
DB00564Carbamazepine4Unknown Status1
DB01202Levetiracetam4Terminated1
DB01202Levetiracetam4Unknown Status1
DB00776Oxcarbazepine4Unknown Status1
DB00860Prednisolone4Unknown Status1
DB00273Topiramate4Completed1
DB00313Valproic acid4Unknown Status1